Home › Funds › Geode Capital Management › ELEV
Geode Capital Management position in ELEV
ELEVATION ONCOLOGY INC
Latest position (Q2 2025)538.66K sh
Reported value held$197.80K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 12.16K | $94.00K | New |
| Q4 2021 | 21.02K | $126.00K | Add |
| Q1 2022 | 26.27K | $66.00K | Add |
| Q2 2022 | 26.27K | $36.00K | Hold |
| Q3 2022 | 90.63K | $102.00K | Add |
| Q4 2022 | 90.34K | $85 | Hold |
| Q1 2023 | 130.38K | $247.72K | Add |
| Q2 2023 | 136.16K | $206.97K | Add |
| Q3 2023 | 230.14K | $152.55K | Add |
| Q4 2023 | 230.14K | $123.63K | Hold |
| Q1 2024 | 348.43K | $1.79M | Add |
| Q2 2024 | 1.03M | $2.79M | Add |
| Q3 2024 | 1.11M | $666.04K | Add |
| Q4 2024 | 1.16M | $651.36K | Add |
| Q1 2025 | 1.19M | $307.43K | Add |
| Q2 2025 | 538.66K | $197.80K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.